Platelet endothelial aggregation receptor-1 (PEAR1) is a cell membrane protein, expressed on platelets and endothelial cells (ECs). PEAR1 sustains aIIbb3 activation in aggregating platelets and attenuates megakaryopoiesis via controlling the degree of Akt phosphorylation. Its role in EC biology is unknown. The aim of this study was to determine the expression of PEAR1 in the human endothelium of various tissues and to investigate its role in ECs in vitro and in angiogenesis, using Pear1 2/2 mice.
Introduction
Cardiovascular disease is the leading cause of death worldwide, 1 in part due to various interactions between platelets and blood vessels. In response to hypoxia, ischaemia, or developmental cues, new capillary sprouts are formed from pre-existing vessels in a process called angiogenesis. These newly formed blood vessels play an important role in crucial processes such as organ growth and repair of wounded tissues, whereas an excessive or insufficient growth of blood vessels contributes to the pathogenesis of numerous disorders (cancer, inflammatory diseases, myocardial infarction, stroke, retinopathy, etc.). 2 -4 The formation of vessels is a complex process, requiring a finely tuned balance between numerous stimulatory and inhibitory signals. Endothelial growth factors (e.g. vascular endothelial growth factor (VEGF), fibroblast growth factor (FGFs), angiopoietins, etc.) are of particular interest because of their key role in angiogenesis, wound healing, arteriosclerosis, and inflammatory reactions. 2, 5 A major signalling event downstream of pro-angiogenic factors is the activation of Akt, which is tightly balanced by phosphatidylinositol 3-kinase (PI3K) and phosphatase-and-tensin homologue (PTEN). 6 Platelet endothelial aggregation receptor-1 (PEAR1) is a 1034-amino acid transmembrane protein, first described in 2005 as a platelet contact activation receptor by Nanda et al. 7, 8 and mainly expressed on platelets and endothelial cells (ECs).
Various genome-wide association and functional genomic studies have suggested a link between common single nucleotide polymorphisms in the PEAR1 locus and increased platelet responses to standard platelet activation agonists, both in control populations and in various cohorts of patients with cardiovascular disease. 9 -12 We have identified a functional role for PEAR1 during platelet activation and demonstrated that PEAR1 signalling sustains the activation of aIIbb3 in aggregating platelets, favouring the formation of stable platelet aggregates. 13 We also observed that PEAR1 attenuates megakaryopoiesis via controlling the activity of the PI3K/Akt/PTEN pathway during megakaryocyte progenitor proliferation. 14 Nevertheless, the abundance of PEAR1 expression in ECs and its role in these cells remain unknown.
To understand the contribution of PEAR1 to (neo)angiogenesis, we studied the effect of PEAR1 deficiency on EC proliferation, migration, and tube formation in vitro and in two revascularization models in vivo in Pear1 2/2 mice. We were able to match our in vitro and in vivo data with the phosphorylation status of Akt, a central player in vessel assembly. 15 2. Methods
EC culture and isolation
The following cultured human EC types were used: freshly isolated blood outgrowth ECs (BOECs), freshly isolated human umbilical vein and artery ECs (HUVECs and HUAECs), and the immortalized HUVEC cell line EAhy926. Confluent cells were cultured to maximally passage six-seven ( 10 -20 days), to avoid senescence. Senescence was monitored by measuring endothelial nitric oxide synthase (eNOS)-mRNA by quantitative polymerase chain reaction 16 in all non-immortalized cells.
All HUVECs and HUAECs used in this article were freshly isolated from human umbilical veins and arteries of healthy volunteers, the day after birth, following a modification of the method of Jaffe et al. 17 Cells were extracted using 0.2% collagenase type 1 (Gibco, Life Technologies, Ghent, Belgium) and seeded on gelatine-coated (0.1%) culture dishes in EBM-2 containing EGM-2 BulletKit (Lonza, Walkersville, USA) and cultured (378C and 5% CO 2 ) until they reached confluence. Each in vitro experiment, performed in this study, has been performed with HUVECs/HUAECs isolated from at least three different umbilical cords (n ¼ 3), with each data point being the mean value of three to four replicates. Formal permission was given by the Ethics Committee of the Leuven University Hospitals to use human umbilical cords (Ref. no. ML8663-Approval S54528), and an informed consent was signed by each mother. BOECs were isolated from blood of healthy volunteers, as reported previously. 18 A more detailed method description is provided in the Supplementary material online. Informed consent was given for the isolation of the blood samples, and this study was granted by the Ethics Committee of the Leuven University Hospitals. The macrovascular EAhy926 cell line [a permanent, easily maintained EC line derived from the fusion of HUVECs and A549 (epithelial)cells 19 ] was grown in Dulbecco's modified Eagle's medium (GIBCO, Pailey, UK), 10% foetal bovine serum (FBS), 1% glutamine, 1.5% sodium bicarbonate, and 0.5% antibiotics (penicillin, 100 U/mL and streptomycin, 100 mg/mL) and was purchased from the American Type Culture Collection, USA. This robust and stable cell line has most of the characteristics of primary cultured ECs. 19 Human microvascular (m)ECs were freshly isolated from heart or liver biopsies, as described. 20 For human heart ECs, biopsies were digested with 1.5 mg/mL collagenase I; for human liver ECs, biopsies were digested with 0.08 Wunsch U/mL liberase and 39 U/mL DNAse. After a final wash in phosphate-buffered saline (PBS), cells were resuspended in fluorescenceactivated cell sorter (FACS) buffer, filtered with a 40 mm mesh, and sorted directly in RLT or TRIzol w [+1% b-mercapto-ethanol (BME)] for RNA extraction. Sorting was performed on the basis of the Tie2+podoplanin-CD45 fraction using a FACS Aria I TM device. For murine mEC isolation, tissues from 8-to 12-week-old Tie2-GFP mice were dissected out, surrounding connective tissue and visible large vessels removed, and tissues enzymatically digested using optimized procedures for each organ [i.e. 1.2 U/mL dispase (BD), followed by Percoll gradient centrifugation for liver; 1.5 mg/mL collagenase I for heart], as described. 20 After a final wash in PBS, cells were resuspended in a FACS buffer (PBS/EDTA, 1 mmol/L/N-2-hydroxyethylpiperazine-N ′ -2-ethanesulfonic acid, 25 mmol/L/1% bovine serum albumin, pH 7), filtered through a 40 mm mesh, and the GFP-positive fraction was sorted on a FACS Aria I (Beckton Dickinson) directly in RLT (Qiagen) or TRIzol (+1% BME) for RNA extraction. Human biopsies were obtained under informed consent. Procedures were approved by the University Hospitals Leuven. All EC studies were performed conform the declaration of Helsinki.
Generation of lentiviral transfer plasmids
Two short hairpin (sh)-based miRNA lentiviral vectors, previously designed and described by our group, i.e. shPEAR1-1461 and shPEAR1-2938, 14 
Real-time quantitative PCR (qRT-PCR)
Total mRNA was extracted with the Qiagen kit (RNeasy mini kit, Hilden, Germany) from cultured cells. cDNAs were synthesized using M-MLV reverse transcriptase (Invitrogen, Ghent, Belgium). Human and murine gene expression was measured using FAM-labelled TaqMan assay products (PEAR1, CIP1/CIP1, PTEN, HIF1a, GAPDH; Applied Biosystems, Life Technologies) or via Sybr Green PCR (FLK1, CDH5, eNOS, and GAPDH; IDT, Leuven, Belgium). qRT-PCR reactions were analysed using an ABI 7000 real-time PCR machine (Life Technologies). Expression was quantified via the DDCt method 21 and expressed in arbitrary units (1 AU is 1 copy for 10 5 copies of housekeeping gene) or in percentage compared with control.
Control ECs were used as a reference for shPEAR1-transduced ECs. Primer sequences are listed in Supplementary material online, Tables S1 and S2.
Western blotting
ECs, serum-starved for 4 h by reducing FBS to 0.1%, were lysed with ice-cold sodium dodecyl sulphate (SDS) lysis buffer (10 mmol/L Tris-HCl pH 8, containing 125 mmol/L NaCl and 1% SDS, 5 mmol/L NaF, 2 mmol/L Na 3 VO 4, protease inhibitor cocktail). Proteins were subjected to SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes in a TransBlot Turbo apparatus (Bio-Rad, Nazareth, Belgium). Membranes were incubated with various primary antibodies overnight: anti-PEAR1-EC (1:1000; R&D Systems), anti-HIF1a (1:1000; R&D Systems), anti-b-actin (1:1000; Cell Signaling), anti-Akt-P (1:500; Cell Signaling), anti-Erk1/2-P (1:1000; Cell Signaling), anti-VEGF and -VEGFR2 (1:500; Cell Signaling), anti-p21 (1:1000; Cell Signaling), anti-CDC2/-Cdc2 (1:1000; Cell Signaling; membranes were stripped and reprobed for GAPDH as loading control), anti-eNOS-S1177 (1:1000; BD), anti-GAPDH/-Gapdh (1:10 000; Fitzgerald), anti-PTEN/-Pten (1:500; Santa Cruz), and anti-p53 (1:1000; Santa Cruz). The PI3K-inhibitor LY294002 was purchased from Calbiochem. After adding horseradish peroxidase-conjugated secondary antibodies, immunoreactive bands were visualized by enhanced chemiluminescence (Amersham Biosciences, Diegem, Belgium). The band intensity was digitally quantified using a Bio-Rad molecular imager (ChemiDoc XRS+, Nazareth, Belgium).
Immunofluorescence and immunohistochemical staining
ECs were seeded on sterile cover slips overnight (378C and 5% CO 2 ). For immunofluorescence (IF), ECs were fixed with 4% paraformaldehyde in PEAR1 in ECs cytoskeleton buffer pH 6. Immunohistochemistry (IHC) for tissue sections was performed using standard protocols with the following antibody dilutions: pre-immune rabbit Ig (1:5; Dako), human anti-PEAR1-EC antibody (5 mg/L; R&D Systems), murine anti-PEAR1-EC Ab (3 mg/L; R&D Systems), human CD31 (2 mg/L; Dako), murine CD31 (2 mg/L; Dako), and PCNA (2 mg/L; Dako). Briefly, sections were deparaffinized using xylol, quenched with ethanol, and antigen retrieval was performed using Dako Target Retrieval Solution (S169984). Subsequently, we incubated tissues with primary antibodies overnight followed by incubation with secondary antibodies for 45 min at RT, 30 min of streptavidin-HRP (1:100; Perkin Elmer), and 8 min of amplification diluent (1:50; Perkin Elmer). Signals were detected using diaminobenzidine (DAB; Sigma Aldrich). Images were taken on a Zeiss microscope with colour camera (Carl Zeiss, Jena, Germany). Negative controls were obtained for each IF and IHC staining.
Proliferation analysis 2.6.1 Time interval cell counting
Non-serum-starved (10% FBS) and serum-starved (0.1% FBS; 4 h) EAhy926 cells and HUVECs (control vs. shPEAR1) were plated in equal numbers (100 × 10 3 ) in six-well plates. At fixed time intervals (22, 44 , and 66 h), cells were trypsinized and manually counted by a blinded observer.
Mitotic count
Serum-starved (0.1% FBS; 4 h) control and shPEAR1 EAhy926 cells were fixed with 4% paraformaldehyde in cytoskeleton buffer pH 6.9 and stained with DAPI Prolong Gold (Invitrogen). A blinded observer counted cellular mitoses for both conditions, using a Zeiss fluorescence microscope. These results were confirmed by automatic counting of mitotic figures, using ImageJ software.
S-phase synthesis analysis
Control and shPEAR1 EAhy926 cells were incubated with EdU (BrdU-alternative; Invitrogen), following the manufacturer's protocol. Active DNA synthesis was measured by the Click-iT w EdU Alexa Fluor w 488 Flow Cytometry Assay Kit (Invitrogen).
Scratch wound assay
HUVECs (4 × 10
5
) were plated in 60 mm tissue culture dishes and allowed to reach confluence (2 -3 days). After aspiration of the medium, a standardized scratch wound was created using a 200 mL micropipette tip. Plates were then rinsed with PBS and incubated (378C and 5% CO 2 ) in EBM-2 medium with or without the PI3K inhibitor LY294002 (dissolved in dimethyl sulphoxide; 10 mmol/L) for the duration of the experiment. Wound closure was followed and photographed up to 12 h. EC migration was determined as the total distance travelled from the initial scratch border. Experiments were analysed by a blinded observer. These experiments were repeated six times (n ¼ 6) with three different HUVEC isolations.
Matrigel tube formation
The capacity of control ECs and lentiviral-transduced shPEAR1 HUVECs and HUAECs to form capillary-like structures (tubes) was evaluated in vitro on matrigel (BD Biosciences, Erembodegem, Belgium). Ice-cold matrigel (200 mL) was added to 24-well plates and allowed to solidify at 378C for 60 min. ECs (1.3 × 10 4 cells) were added in 250 mL EBM-2 medium with EGM-2 BulletKit (Lonza, Walkersville, MD, USA) and blasticidin (50 mg/ L). Cells were incubated at 378C with humidified 95% air/5% CO 2 for 16 h. Tubes were visualized using a Zeiss microscope and photographed. The number of branching points, total tubes, and number of tubes were counted manually by a blinded observer and were confirmed using ImageJ.
Images were analysed at ×50 magnification. 
Pear1-knockout mouse

Hind limb ischaemia model 2.10.1 Surgery and isolectin staining gastrocnemius muscle
This method was adapted from Limbourg et al. 5 Briefly, 11-week-old C57BL/6N-mice were sedated with an intraperitoneal injection of ketamine (125 mg/kg body weight)/xylazine (12.5 mg/kg body weight). The left proximal femoral artery was double ligated and cut in the middle. Laser-Doppler imaging (LDI) was performed immediately after surgery to evaluate the efficiency of flow interruption. At day 21, mice were sacrificed using an overdose of intraperitoneal pentobarbital (70 mg/kg). Gastrocnemius muscles were excised and fixed with 4% paraformaldehyde. Tissue sections were obtained using standard protocols and stained with the Alexa Fluor 568-labelled lectin (GS-IB4, Invitrogen). Micrographs were obtained using a Zeiss fluorescence microscope, and isolectin-positive vessels were counted manually. Results were expressed as number of vessels per area in square millimetres.
Laser-Doppler imaging (LDI)
The animals were placed on a pre-heated plate (37.48C) to avoid vasoconstriction by anaesthetic heat loss and sedated with isoflurane inhalation. A Laser-Doppler imager (PIM II-Laser Doppler Perfusion Imager, Lisca AB, Sweden) was used to estimate relative blood flow in the paws. To correct for variables, including ambient light and temperature, calculated perfusion was expressed as a ratio of the ischaemic (left) to non-ischaemic (right) limb at each time point (LDPIwin software, Perimed, Sweden). Measurements were performed at a pixel resolution of 64 × 64. Results per time point were calculated as the mean of five images per time point.
Micro-computed tomography (mCT) visualization
The vasculature in the gastrocnemius muscle was visualized 21 days after unilateral (left) femoral artery ligation in Pear1 +/ + (WT) and Pear1
mice. Therefore, mice were sedated with an intraperitoneal injection of ketamine (125 mg/kg body weight)/xylazine (12.5 mg/kg body weight) and perfused with 0.2% adenosine for vasodilatation, followed by 4% paraformaldehyde for fixation, subsequently saline to wash out the fixative, and finally with a pre-heated solution of 30% barium sulphate (Micropaque, Guerbet) as a contrast agent in 2% gelatin. Mice were stored on ice at 48C overnight to solidify the gelatin with the contrast agent in the vessels. After overnight solidification, limbs were dissected out, stored in PBS, and imaged with the SkyScan 1172 micro-CT system, using a peak tube voltage of 50 kV, a current of 200 mA, a filter of 0.5 mm aluminium, and an exposure time of 590 ms. The FDK algorithm of the manufacturer (NRecon, SkyScan, Kontich, Belgium) was applied to reconstruct the data set into a three-dimensional (3D) image with an isotropic voxel size of 8 mm. The data set was downsampled by a factor 2 for reasons of computational feasibility and subsequently visualized using custom-made software developed in MeVisLab (MeVis Medical Solutions AG and Fraunhofer MEVIS, Bremen, Germany). Therefore, the bone was manually delineated and excluded from the volume of interest. The blood vessels were segmented using hysteresis thresholding, and fragments smaller than 10 voxels were excluded to minimize the influence of noise, rendering a visualization of the vascular network in the gastrocnemius muscle. The methods used to harvest muscle tissues and the methods to extract protein and mRNA in order to determine the concentrations of HIF1a, VEGF, and VEGFR2 are described in the Supplementary material online.
Skin wound-healing model
Mice were sedated with an intraperitoneal injection of ketamine (125 mg/kg body weight)/xylazine (12.5 mg/kg body weight). Full-thickness skin wounds (29 mm 2 ) were made on the back of Pear1 2/ 2 mice (C57BL/ 6N) and their littermates, using a dermal biopsy puncher. Wounds were splinted with a silicone ring, moistened with saline, and covered with a Tegaderm dressing. Every other day, a digital picture of the wounds was taken (Canon digital Camera), wound dimensions were measured under isoflurane anaesthesia, and the dressing was renewed. Mice were sacrificed at day 4 or day 8 using an overdose of intraperitoneal pentobarbital (70 mg/kg). Granuloma tissue was dissected using a Leica M650 microscope, and tissues were pooled for each group in SDS loading buffer and ribolysed for conventional western blotting.
Statistical analysis
For some experiments, the number of replicates is presented in the figure legend. The replicate number is the total number of analyses performed to calculate an averaged value, statistically treated as 1 data point (e.g. n ¼ 3, six replicates represent 3 × 6 measurements, for which three averages are calculated, reported as n ¼ 3). Results are expressed as mean + SEM. Statistical significance was evaluated with unpaired Student's t-tests and oneway or two-way analysis of variance (ANOVA) with Bonferroni's post-test correction or linear regression. Asterisk indicates P , 0.05.
Results
PEAR1 expression in human ECs
In this first study addressing the role of PEAR1 in ECs, we performed a detailed analysis of its expression in various human tissues ( Figure 1) . IHC staining for PEAR1 and the specific EC marker CD31 confirmed comparable expression of both proteins in the human liver, lung, and kidney, substantiating expression of PEAR1 in ECs primarily ( Figure 1A) . Double IF staining for CD31 and PEAR1 co-localized both proteins in the endothelium of the human renal glomerulus ( Figure 1B) . IF staining for PEAR1 in freshly isolated HUVECs ( Figure 1C , upper panel) and confluent immortalized HUVECs (EAhy926 cells; Figure 1C , lower panel) revealed PEAR1 in the cell membrane and in the filo-and lamellipodia of ECs. PEAR1 mRNA was detected in BOECs, in ECs from human umbilical cord (EAhy926, HUAECs, and HUVECs), and in microvascular ECs (mECs) isolated from the vascular beds of human liver and heart and lysed immediately after isolation. The mRNA expression of PEAR1 was heterogeneous with the lowest expression in less-differentiated ECs (BOECs) and the highest in freshly isolated mECs from heart and liver tissue. mRNA of HUAECs and HUVECs (lysed immediately after isolation from umbilical cords) and cultured EAhy926 ECs revealed intermediate levels of PEAR1 mRNA ( Figure 1D ). Protein levels (WB) were low in BOECs and comparable for HUAECs, EAhy926, and HUVECs. Protein levels of mECs could not be determined, due to the small amount of ECs that could be isolated from the human liver and heart biopsies only.
PEAR1 knockdown enhances EC proliferation
To investigate the role of PEAR1 in ECs, we first performed a knockdown of PEAR1 by double miRNA-based sh-constructs (shPEAR1). This was achieved via two different shPEAR1 constructs, both reducing PEAR1 mRNA expression by approximately 70% (Figure 2A , HUVECs and EAhy926; Supplementary material online, Figure S1 ), and confirmed by the concomitant reduction of PEAR1-protein levels ( Figure 2B ; cultured HUVECs and EAhy926; WB) compared with control ECs. Similar results were observed in cultured shPEAR1 HUAECs (data not shown). PEAR1 knockdown increased the proliferation rate in various ECs. Twenty-two hours after seeding, a two-fold higher number of HUVECs was observed in the shPEAR1 group when compared with the control group, both in non-starved ( Figure 2C ) and in starved (data not shown) ECs. Similar results were seen when EAhy926 cells were studied ( Figure 2C , right panel). Evaluation of serum-starved EAhy926 cell proliferation by flow cytometry showed an increased incorporation of the fluorescent BrdU-analogue EdU in the shPEAR1 vs. control cells ( Figure 2D ). The assessment of the number of EC mitoses (DAPI-stained control and shPEAR1 EAhy926 cells; 22 h after seeding) by a blinded observer confirmed a two-fold increase in shPEAR1 vs. control ECs (17.3 + 2.1 vs. 9.5 + 0.9%; P , 0.05). Thus, in the steady state, 70% knockdown of PEAR1 results in a doubled cell count in vitro. This interpretation is supported by low PEAR1 levels in ECs with a high proliferative phenotype (e.g. BOECs; Figure 1D ) and by our finding that highly proliferative ECs of a pyogenic granuloma (a fast growing endothelial skin tumour) express lower PEAR1, compared with the expression in ECs of normal skin in the same tissue section (Supplementary material online, Figure S2 ).
Knockdown of PEAR1 modulates EC proliferation via Akt/p21/CDC2
Our previous work demonstrated a tight link between PEAR1 and PI3K/Akt activation in platelets and megakaryocytes. 13, 14 To unravel the mode of action of PEAR1 in ECs, we selected the immortalized EAhy926 cells to avoid effects of senescence throughout different cell passage numbers. Western blots revealed constitutively increased phosphorylation of Akt (S473) in shPEAR1 vs. control ECs ( Figure 3A ; 5.1-fold increase) both in confluent and in non-confluent cells, indicating a confluence-independent enhanced Akt-phosphorylation state. The MAPK pathway (Erk1/2) was not affected by PEAR1 knockdown (Supplementary material online, Figure S8 ). At the same time, we found a decrease of PTEN expression (HUVECs and EAhy926) and p21/CIP1 (EAhy926 cells) in shPEAR1 ECs, both at the protein (WB; n ¼ 3) and the mRNA levels (qRT-PCR; n ¼ 3; Figure 3A ). p21/CIP1 is an Aktcontrolled nuclear suppressor of EC proliferation via p34/CDC2, a cyclin that regulates G2-to-M transition during cell division. Accordingly, we found a 4.7-fold up-regulation of p34/CDC2 in the shPEAR1 EC group ( Figure 3A) . This up-regulation of p34/CDC2 in shPEAR1 ECs was reversed to basal CDC2 levels in the presence of the PI3K-inhibitor LY294002 ( Figure 3B) , indicating a direct link between PEAR1 in ECs the phosphorylation of Akt and CDC2 expression, explaining the association between increased Akt-P and the up-regulation of CDC2 in shPEAR1 ECs. IF staining of EAhy926 cells (shPEAR1 vs. control ECs) for p21 and nuclear DAPI showed a nuclear localization of p21 in control ECs and a strong shift of p21 towards the cytoplasm in shPEAR1 ECs, consistent with increased mitosis (Supplementary material online, Figure S3 ). A critical role for Akt in proliferation and angiogenesis can be mediated by the Akt-downstream effector eNOS. However, the mRNA expression of eNOS and the degree of phosphorylation of eNOS (S1177) were not affected in shPEAR1 ECs. We confirmed that shPEAR1 ECs did not produce higher levels of NO as measured with DAF-FM diacetate (Supplementary material online, Figure S4A , EAhy926 cells and Supplementary material online, Figure S4B , HUVECs) and that functional relaxation experiments of WT thoracic aortic segments vs. Pear1 2/2 aortic segments did not show any differences in Ach-induced aortic relaxation or during PE-induced vasoconstriction in the absence of NO production (Supplementary material online, Figure S4C ) . We conclude that PEAR1 controls the expression of PTEN and that the drop of PTEN in shPEAR1 ECs is associated with the increased phosphorylation status of Akt, leading to enhanced cell cycle progression due to an increase in CDC2 expression ( Figure 3C ), in turn caused by a shift of nuclear p21/CIP1 towards the cytoplasm and a down-regulation of total p21/CIP1 levels.
Knockdown of PEAR1 enhances EC migration in vitro
Migration of ECs is an essential process in (neo)angiogenesis 22 and is known to be mediated via phosphorylation of Akt. 22 As PEAR1 was found to be highly expressed at filo-and lamellipodia of ECs, in EC ruffles, and at the migratory border of low confluent ECs ( Figure 4A) , suggesting a role for PEAR1 in EC migration, we performed in vitro migration assays and demonstrated enhanced cellular migration of shPEAR1 HUVECs vs. control ECs. Migration was analysed within a 12 h time window to avoid confounding interference of effects on EC proliferation. Analysis of the migration distance in a cell migration assay revealed up to threefold higher migration for the shPEAR1 ECs ( Figure 4B ). Interestingly, this enhanced shPEAR1-induced migration was abrogated in the presence of the PI3K inhibitor LY294006 (10 mmol/L; Figure 4C ).
PEAR1 controls in vitro tube formation
As both EC proliferation and migration are important players in blood vessel formation, we further investigated whether the PEAR1 knockdown would affect tube formation in a matrigel assay, using control and shPEAR1 HUVECs and HUAECs. Tubes were evaluated 16 h after EC seeding ( Figure 5A ). We observed a significant increase in the number of branching points, number of tubes, and the total tube length in shPEAR1 HUVECs, compared with control HUVECs ( Figure 5B) . Similar results were found for both shPEAR1 constructs ( Figure 5C ) and lentiviral-transduced HUAECs (data not shown). The mRNA levels of three typical EC markers (KDR/VEGFR2, CD31/PECAM1, and VEcadherin/CDH5) were mildly up-regulated during tubulogenesis, but no significant differences between control and shPEAR1 ECs were observed (Supplementary material online, Figure S5 ), suggesting that endothelial identity was not affected by PEAR1 knockdown. The expression of PEAR1 and PTEN was measured in control and shPEAR1 HUVECs by qRT-PCR at the beginning and end of the tube formation process ( Figure 5D ). PEAR1 was up-regulated in control ECs during tubulogenesis (left panel), in parallel with up-regulation of PTEN mRNA levels (right panel). Interestingly, in shPEAR1 ECs, PTEN expression was , shift of p21/CIP1 towards the cytoplasm, reduction of the nuclear p21/ CIP1-mediated suppression of CDC2, and ultimately resulting in increased EC proliferation due to an enhanced CDC2-driven cell division. Results are given as mean + SEM; unpaired t-test was applied; *P , 0.05.
very low, both before and during tubulogenesis (right panel). These findings suggest that PEAR1 controls the in vitro tube formation, leading to enhanced tubulogenesis upon its absence, compatible with a role in EC proliferation and migration.
Expression of Pear1 in different murine ECs
Subsequently, we investigated the Pear1-expression pattern in mice by qRT-PCR and IHC and confirmed the expression of Pear1 (vs. Gapdh) Figure S6A ). The absence of Pear1 in blood vessels from Pear1 2/2 mice (skin) confirmed the specificity of the anti-Pear1 antibody used (IHC; Supplementary material online, Figure S9 ). Figure S6B ) and haematoxylin and eosin staining (data not shown) of murine lung, kidney, and liver tissue did not reveal structural differences or fluctuations in the blood vessel density between Pear1 2/2 mice and their WT littermates.
Pear1 controls neoangiogenesis in vivo
Next, we examined whether the role of PEAR1 in tubulogenesis in vitro could be at play during angiogenesis in vivo in mice. Therefore, two established models of neoangiogenesis were studied in Pear1 2/2 mice.
Ischaemia-induced angiogenesis in Pear1 2/2 mice
Hind limb ischaemia is a pre-clinical model for peripheral arterial disease, in which both arteriogenesis and angiogenesis are induced upon femoral artery ligation. After the ligation of the femoral artery, increased shear stress triggers outward collateral remodelling in the adductor muscle, whereas the more distal gastrocnemius becomes hypoxic, triggering an angiogenic response in the lower leg. 5, 23 Therefore, we adopted this hypoxia model to investigate angiogenesis in the gastrocnemius muscle after ligation of the femoral artery in Pear1 Figure S7 ).
PEAR1 in ECs
The density of isolectin-positive capillaries was 2.4-fold higher in Pear1 2/ 2 compared with WT mice, which supports the enhanced angiogenesis in the gastrocnemius muscle in Pear1 2/ 2 mice after chronic hind limb ischaemia ( Figure 6B ). Capillary density in non-ligated limbs of Pear1 2/2 was comparable with that in WT mice, supporting our findings that PEAR1 does not affect embryological vascular development ( Figure 6B) . A 3D reconstruction by micro-CT (CT angiography after barium instillation) of the gastrocnemius at the ligated side (day 21) confirmed a stronger angiogenic response and a hence denser vascular network in the Pear1 2/2 mice, compared with WT littermates (representative images in Figure 6C ). Micro-CT images of nonligated hind limbs revealed no differences in the vessel density between 
Pear1
2/2 and WT mice (Supplementary material online, Figure S7 ), in agreement with our histological analysis. As it was previously shown that knockdown of PTEN -as seen in shPEAR1 ECs -can increase the expression levels of VEGF via the Akt/HIF1a/VEGF pathway, 24 -28 we thoroughly investigated the role of VEGF in the hind limb ischaemia model. However, the expression of HIF1a, VEGF, and its receptor VEGFR2 following hind limb ligation did not differentially increase in WT vs. Pear1 2/2 mice (Supplementary material online, Figure S8 ), excluding a regulatory role for Pear1 in VEGF signalling (see Supplementary material online for further details).
Capillary wound density and wound closure in Pear1
2/2 mice Wound healing is the result of a complex interaction among keratinocytes, various growth factors, and vascularization. 29, 30 We performed a standardized wound-healing assay to study EC proliferation during wound closure in Pear1 Figure S10 ). To correlate the underlying mechanistic pathway responsible for this enhanced vascularization and proliferation in Pear1 2/2 mice with our in vitro findings, we pooled the granuloma tissue of five mice per group, performed western blot analysis for mCD31, mAkt-P, and mCdc2, and found a strong up-regulation of these three key players in Pear1 2/2 vs. WT mice ( Figure 7D) . Thus, increased blood vessel formation contributes to the enhanced wound closure rate in Pear1 2/ 2 mice, ECs being the only Pear1-positive cells in the regenerating wound.
Discussion
PEAR1 is a transmembrane protein expressed on the cellular border and on filo-and lamellipodia of ECs. So far, the role of PEAR1 signalling in the vascular endothelium during angiogenesis has remained undefined. Herein, we report that knockdown of PEAR1 in cultured human ECs resulted in increased tube formation in vitro and that knockout of Pear1 resulted in enhanced angiogenesis in two established in vivo mouse models.
In various human tissues, the presence of PEAR1 in ECs was demonstrated at both mRNA and protein levels. We observed a lower PEAR1 expression in rapidly proliferating cultured ECs (BOECs, HUVECs, and HUAECs) and a higher expression in slow-proliferating mECs of the heart and liver. Also in rapidly proliferating ECs of a pyogenic granuloma, a hypervascularized skin tumour, an inverse association between PEAR1 expression and EC proliferation, was observed. It was of particular interest that PEAR1 expression rose 2.3-fold during in vitro tube formation. All these results suggested a modifier function for PEAR1 on endothelial angiogenic behaviour, leading to an increased proliferation rate and tube-forming capacity upon its absence, similar to our previous findings of enhanced megakaryopoiesis in shPEAR1 CD34+ cells.
14 This hypothesis was confirmed by lentiviral knockdown of PEAR1; knockdown reduced PEAR1 expression by 70% and resulted in a doubled proliferation rate for these shPEAR1 ECs.
The augmented proliferation was documented via a manual EC counting technique, via flow cytometric assessment of EC EdU incorporation, 31 and via direct analysis of the number of cellular mitoses. This doubled proliferation rate was confirmed applying two different miR-NA lentiviral vectors in different human cultured ECs. Next, we unravelled the underlying mechanistic pathway responsible for enhanced EC proliferation in PEAR1-knockdown cells. Signalling of receptor tyrosine kinases through mitogen-activated protein kinases (MAPKs) and PI3K/Akt are the two major pathways in EC proliferation. 32, 33 We observed that knockdown of PEAR1 in ECs resulted in increased baseline Akt phosphorylation, accompanied by a downregulation of the expression of the phosphatase PTEN, priming ECs to adopt a more proliferative phenotype. This is in line with our previous report showing that a similar PEAR1-dependent Akt-driven mechanism is operative during megakaryopoiesis. 14 Cell cycle progression in ECs is tightly regulated by the family of cyclin-dependent kinase inhibitors. The increased Akt activity upon PEAR1 knockdown was associated with a decrease of nuclear p21 CIP1/WAF1 and elevated the cytosolic localization of p21
, an important regulatory mechanism of mitosis. 34 These findings provided a molecular basis for the enhanced CDC2-driven EC proliferation. Indeed, p21 CIP1/WAF1 inhibits the activity of CDC2, a cyclin that regulates G2-to-M transition during cell division. 35 In HER-2/neu-overexpressing cells, it was established that growth inhibition is coupled to nuclear localization of p21
. PI3K/Akt-driven phosphorylation of p21 CIP1/WAF1 resulted in the cytoplasmic localization of p21
, which is no longer effective in suppressing CDC2. 36, 37 These enhanced levels of CDC2 in shPEAR1 ECs could be reversed by inhibition of PI3K, indicating a direct link between elevated Akt-P levels upon PEAR1 knockdown and enhanced proliferation. The Erk pathway represents one of the best characterized MAPK signalling pathways in EC proliferation. 38 However, PEAR1 knockdown did not affect the phosphorylation of Erk1/2. ECs will rapidly form capillary-like structures in vitro when plated on top of a reconstituted, VEGF-containing basement membrane extracellular matrix (matrigel). This differentiation process, used as an in vitro assay of angiogenesis, involves several steps in blood vessel formation, including cell adhesion, migration, alignment, and tubule formation. 39, 40 We observed an up-regulation of PEAR1 during tube formation in vitro, and we illustrated that endothelial PEAR1 knockdown boosted the in vitro tube formation, underpinning a significant role for PEAR1-modulated EC proliferation during tube formation. A major signalling event downstream of pro-angiogenic factors such as, e.g. VEGF, is the activation of Akt, both in vitro and in vivo. 15, 41, 42 Although we were unable to measure Akt-P before and after tube formation, due to the small amount of available cells, we were able to measure it indirectly by qRT-PCR for PTEN, as the inverse correlation between phosphorylation levels of Akt and expression levels of PTEN has been well established. 43 We not only observed a lower expression of PTEN in shPEAR1 ECs before tube formation as discussed earlier but also a lack of the physiological PTEN enrichment during tubulogenesis, 44, 45 indicating a permanent lack of dephosphorylation of Akt during shPEAR1 tube formation. Expression levels of other important markers of terminal EC differentiation (VE-cadherin, VEGFR2, or PECAM1) were not significantly affected during tube formation upon PEAR1 knockdown. It has been reported that critical roles of Akt in angiogenesis can be regulated by the Akt-downstream effector eNOS. 46, 47 Enhanced nitric oxide (NO) synthesis could be the explanation for the increased EC proliferation and angiogenesis, observed upon PEAR1 knockdown. However, we observed no differences in eNOS phosphorylation (activating site, S1177) upon PEAR1 knockdown, could not detect any differences in NO production (DAF-FM dye) of shPEAR1 ECs compared with control cells in vitro, and were not able to show any differences in functional aortic relaxation experiments of WT vs. Pear1 2/2 aortas. Therefore, it is unlikely that NO accounts for the observed phenotype. Vascular assembly is a complex interaction among EC proliferation, migration, and sprouting.
22 PEAR1 was strongly positive at the tips of endothelial filo-and lamellipodia and was found to be expressed in endothelial ruffles. As we found enhanced tube formation at early time points on matrigel assays upon PEAR1 knockdown and as it has been previously reported that constitutively enhanced phosphorylation levels of Akt strongly promote EC migration, 48 Angiogenesis is also central to granulation tissue formation, because the ingrowth of newly formed vessels is needed to ensure the supply of oxygen and nutrients to the regenerating tissue. Wound healing is the result of a complex interaction among keratinocytes, fibroblasts, and neoangiogenesis, resulting from growth factor-induced (FGF, VEGF, TGF-b, etc.) EC proliferation and migration. 29, 30, 53 The expression of Pear1 in the endothelium of skin tissue was documented, and we showed ECs to be the only Pear1-positive cells via IHC. At day 4 of wound healing, there was an approximately two-fold increase in the speed of wound closure (t 1/2 of full recovery was 4 days in KO mice and 7 days in WT mice) in Pear1 2/2 mice, compared with their WT lit-
termates. This was accompanied by increased cell proliferation (by PCNA staining) and increased angiogenesis in the wound areas of Pear1 2/2 mice.
The difference in the healing rate remained present until the time point of sacrifice on day 8. The faster wound closure in Pear1 2/2 mice could be explained by enhanced neo-formation of blood vessels in the wound surface and was illustrated by enhanced positivity for CD31, both by IHC and by WB of the granuloma tissue of Pear1 2/2 mice.
Angiogenesis constitutes an important aspect of EC function, and PI3K/Akt signalling is critical in these processes. 15, 41, 54 We were able to demonstrate, in parallel with our in vitro findings, an enhanced Akt-P-driven Cdc2 up-regulation in the pooled granuloma tissues of the Pear1 2/2 mice when compared with littermates at day 4 of wound healing. This allowed us to extrapolate our in vitro signalling data to those of the in vivo wound healing assay and supported the controlling role for PEAR1 in Akt-driven proliferation/migration of ECs and angiogenesis via the PI3K/Akt pathway. It remains to be shown how PEAR1 controls PI3K/PTEN, but an inverse relation between Akt-P and PTEN has been shown in many cell types. 22 Although we excluded a modulating role for Pear1 in HIF1a/VEGF signalling, other important signalling pathways are implicated in angiogenesis (e.g. NOTCH, mTOR pathway, integrins, etc.), 55 -58 potentially contributing to further regulation of Akt phosphorylation and its effects on angiogenesis. This work reveals PEAR1 as a modulatory factor of vascular assembly. We previously showed a role for PEAR1 in mekaryocyte proliferation but also a role for PEAR1 as a contact receptor in platelet aggregation. Platelet PEAR1 is phosphorylated via c-Src upon stimulation with the high-affinity immunoglobulin E-binding subunit FceR1a (ligand for platelet PEAR1) 59 and with a polyclonal anti-PEAR1 antibody, acting as a pseudo-ligand. 13 So far, the physiological ligand for PEAR1 on ECs remains to be identified.
In conclusion, we identified PEAR1 as a novel modifier of neoangiogenesis. This study will trigger further research on the role of PEAR1 in pathological endothelial hyperproliferation (as seen in, e.g. neo-intima formation after stent implantation 60 or in pulmonary hypertension 61 ) and on the interaction between platelets and ECs, two major players in cardiovascular disease. Further research will also need to identify how various SNPs regulate the expression of PEAR1 and whether PEAR1 contributes to pathologies with excessive vessel growth, e.g. inflammatory diseases, retinopathy, and cancer. 2 
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